The Taipei District Court has found a veterinarian criminally liable for using banned veterinary medicines during chemotherapy on a Maltese dog.
A man surnamed Lin (林) had his dog, named “Angel,” undergo surgery followed by a 12-week chemotherapy regimen at the Eden Animal Hospital in Taipei at the end of 2021 to treat a mast cell tumor.
However, Angel died of acute renal failure in January the following year.
Photo courtesy of the pet owner surnamed Lin
Lin suspected that Angel’s death was caused by an overdose of toceranib, a tumor-targeted drug that is banned for veterinary use in Taiwan.
Lin said the veterinarian administered the banned drug to his dog without his consent and continued the therapy despite severe side effects, adding that the medicine could have been counterfeit, citing its suspicious sources.
In 2022, Lin sought help from then-Democratic Progressive Party lawmaker Kao Chia-yu (高嘉瑜), who raised the issue during a legislative session, and demanded that the then-council of agriculture explain why it had tolerated the illegal use of banned veterinary drugs that “resulted in the death of a dog.”
Her accusations drew criticism from other pet owners and veterinarians, citing the drug’s legality in other countries and that the use of such medicines in Taiwan was often a practical necessity in the absence of alternative treatments.
The incident prompted Kao to advocate for the liberalization of restrictions on veterinary drug imports, while Lin faced a backlash from many Internet users and continued to gather evidence to file a lawsuit against the hospital.
Last year, the hospital’s former superintendent Kao Mao-jen (高茂仁) and veterinarian Hung Yi-ping (洪一平) were convicted of selling banned veterinary medicines, contravening Article 35 of the Veterinary Drugs Control Act (動物用藥品管理法).
The judge in the ruling said Kao and Hung should be held responsible for disrupting the veterinary medicine management system by selling the banned therapy.
In their defense, Kao and Hung said the veterinary therapy was specifically developed to treat mast cell tumors and was not legally available in Taiwan at the time, as no supplier had submitted an application for its importation.
Given that defendants used and sold the therapy in an effort to treat the dog’s disease and admitted wrongdoing, they were given the minimum statutory penalty — a four-month prison sentence, convertible to a fine of NT$1,000 per day, along with two years’ probation, the judge said, adding that they were also required to attend two sessions of a legal education class.
Their conviction made Lin the first person in Taiwan to receive a NT$150,000 monetary reward from the Animal and Plant Health Inspection Agency for reporting the use of banned veterinary drugs.
Lin said that his objection was not to the legal approval of toceranib in Taiwan, but to the use of unapproved, potentially counterfeit medicine from a suspicious source.
The hospital said there was no alternative to toceranib in Taiwan and their prescribed dosage was safe, but imatinib, a legally approved tumor-targeting drug, was available at the time, Lin said. He thanked the court for its ruling.
Kaohsiung Animal Protection Office consultant and attorney Chin Jui-yun (秦睿昀) on Friday said that Lin’s case took place before the launch of the veterinary drug import project, which now allows veterinarians to legally import and use medications unavailable in Taiwan by registering their import plans with the Taiwan Veterinary Medical Association.
Chin also urged the Ministry of Agriculture to amend the law by adding an exclusion clause, which he said would help prevent veterinarians from unintentionally contravening the law.
Seven of the 17 NT$10 million (US$311,604) winning receipts from the November-December uniform invoice lottery remain unclaimed as of today, the Ministry of Finance said, urging winners to redeem their prizes by May 5. The reminder comes ahead of the release of the winning numbers for the January-February lottery tomorrow. Among the unclaimed receipts was one for a NT$173 phone bill in Keelung, while others were for a NT$5,913 purchase at Costco in Taipei's Neihu District (內湖), a NT$49 purchase at a FamilyMart in New Taipei City's Tamsui District (淡水), and a NT$500 purchase at a tea shop in New Taipei City's
Taiwanese officials were shown the first of 66 F-16V fighter jets purchased by Taiwan from the United States, the Ministry of National Defense said yesterday, adding the aircraft has completed an initial flight test and is expected to be delivered later this year. A delegation led by Deputy Minister of National Defense Hsu Szu-chien (徐斯儉) visited Lockheed Martin’s F-16 C/D Block 70 (also known as F-16V) assembly line in South Carolina on March 16 to view the aircraft. The jet will undergo a final acceptance flight in the US before being delivered to Taiwan, the
Deliveries of delayed F-16V jets are expected to begin in September, Minister of National Defense Wellington Koo (顧立雄) said today, after senior defense officials visited the US last week. The US in 2019 approved a US$8 billion sale of Lockheed Martin F-16 jets to Taiwan, a deal that would take the nation’s F-16 fleet to more than 200 jets, but the project has been hit by issues including software problems. Koo appeared today before a meeting of the legislature’s Foreign Affairs and National Defense Committee, which is discussing different versions of the special defense budget this week. The committee is questioning officials today,
TALENT SCOUTING: The university is investing substantial funds in its future to bring in the kind of researchers that would keep the college internationally competitive National Taiwan University (NTU) plans to invest NT$2 billion (US$62.6 million) to launch two programs aimed at attracting and retaining top research talent, university president Chen Wen-chang (陳文章) said yesterday. The funding would support the “Palm Grove Scholars Project,” which targets academics aged 40 to 55. Up to 20 scholars would be selected, each receiving as much as NT$10 million annually, Chen said. The initiative is designed to attract leading researchers to Taiwan and strengthen NTU’s global competitiveness by fostering a more research-friendly environment and expanding international collaboration, he said. NTU is also introducing a “Hong Hu” chair grant, which would provide Palm